Monotherapy with liraglutide immediately resulted in a pronounced suppression of body weight, however, the magnitude of weight loss was then stable over the 30-days treatment period
R.TasleemM.JainM.AhujaS.GoswamiS.BakshiS.et al
Group B: It consisted of 45 healthy individuals without a clear history of previous COVID-19 infection and were all subjected to routine blood testing to monitor their health status
Overall, the authors conclude that: The recognition that several gastrointestinal hormones, released in response to nutritional stimuli are important regulators of appetite (PYY, oxyntomodulin, GLP-1 and decreased secretion of ghrelin), offers a strategy for the development of more effective ant-iobesity agents.treatment of obesity could involved a combination of hormones, e.g
Choosing a safe GLP-1 requires understanding your unique risk factors and genetic predispositions in peptide metabolism
Tradjenta contains the drug linagliptin